Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Carola S. König has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Testosterone Undecanoate Significantly Reduces Low Density Lipoprotein Cholesterol and Triglycerides in Men With Adult‐Onset Testosterone Deficiency

    by Anirudh Bhat, Arjun Ajith Kumar, Michael Zitzmann, Farid Saad, Carola S. König, Karim Sultan Haider, Ahmad Haider, Geoffrey Hackett, Pieter Desnerck, John Marriott, et al.

    Background: Adult‐onset testosterone deficiency, a condition characterised by low serum testosterone and hypogonadal symptoms is associated with a higher incidence of cardiovascular disease (CVD) and mortality. Objective: To evaluate associations between change (Δ) in total cholesterol (TC), triglycerides (TG) and low‐density lipoprotein (LDL)‐cholesterol and testosterone undecanoate (TU) treatment. Materials & Methods: We analysed a registry of men with adult‐onset TD (409 TU‐treated and 415 TU‐untreated men, median follow‐up 153 months), restricting the analysis to men whose statin treatment was not changed during follow‐up, thus avoiding statin related effects. The study cohort comprised the following groups: TU‐untreated/not on statins ( n = 95), TU‐untreated/on statins ( n = 245), TU‐treated/not on statins ( n = 194), and TU‐treated/on statins ( n = 207). Intra‐group non‐parametric statistics were performed as baseline characteristics varied between the study groups. We used multivariate and logistic regression models to determine predictors of ∆ lipids (LDL‐cholesterol and TG) and mortality. Results: Whilst there was a significant decrease in LDL‐cholesterol and TG (mostly in the initial 24 months) in the TU‐treated men, the reverse was evident in the untreated men, irrespective of concurrent statin therapy. Baseline LDL‐cholesterol and TG inversely predicted ∆ values in the TU‐treated men, regardless of statin therapy. LDL‐cholesterol at final assessment appeared independently associated with mortality. Conclusions: In this long‐term, real‐world registry, TC, TG, and LDL‐cholesterol decreased in the TU‐treated men with baseline values predicting the change, whilst a gradual increase was observed in the TU‐untreated men. Using published data, the relative risk reduction in CVD due to LDL‐cholesterol reduction is estimated to be around 40%.

  • Open Access

    Process-Based Mechanisms and Lifecycle Mitigation of Clogging in Interlocking Permeable Pavements: Critical Insights for Sustainable Urban Drainage Systems

    by Bockarie Samai, Abiy S. Kebede, Carola S. König, Pedro Martin-Moreta, Alalea Kia

    Interlocking permeable pavements (IPPs) are increasingly adopted within sustainable urban drainage systems to reduce runoff, improve water quality, and strengthen climate-resilient urban infrastructure. However, clogging remains the principal constraint on their long-term hydraulic performance and wider implementation. This review synthesises current evidence on clogging mechanisms, hydraulic decline, and lifecycle mitigation strategies for permeable interlocking concrete pavements (PICPs), concrete grid pavements (CGPs), and plastic grid pavers (PGPs). The literature is dominated by PICP studies, with CGP and PGP underrepresented, restricting typology-specific assessment. Sediment accumulation within joints, grid openings, bedding layers, and near-surface interfaces is consistently identified as the primary clogging mechanism, while traffic, rainfall-runoff loading, biological processes, pollutant retention, and sediment inputs from adjacent impervious surfaces further influence hydraulic deterioration. The findings indicate that hydraulic performance is influenced not only by pavement age but also by interactions among pavement design, filler or joint material, drainage configuration, construction quality, sediment exposure, monitoring, and maintenance. Effective mitigation therefore requires lifecycle management, encompassing source control, pretreatment, appropriate material selection, construction quality assurance, routine hydraulic monitoring, and timely preventive and restorative maintenance. Future research should prioritise standardised clogging assessment protocols, improved laboratory–field integration, targeted investigation of CGP and PGP, biological and pollutant-linked clogging processes, climate-driven rainfall extremes, and decision-support.


  • Open Access

    The association between age and mortality in men with adult-onset testosterone deficiency is altered by testosterone therapy

    by Amar Mann, Richard C Strange, Carola S König, Geoffrey Hackett, Ahmad Haider, Karim Sultan Haider, Peter Desnerck, Michael Zitzmann, Farid Saad, Mruga M Dhebar, et al.

    Using the Gompertz-Makeham model, we describe associations between age and the probability of mortality in men with adult-onset testosterone deficiency (TD), stratified by testosterone undecanoate (TU) treatment and type 2 diabetes (T2DM). We analyzed a registry of 737 men (353 and 384 men on/not on TU, respectively) with adult-onset TD with nearly 9 years of follow-up. We compared associations between age and mortality using nonparametric and logistic regression models (estimating individual mortality probability) in men stratified by TU treatment and T2DM. Mortality was lower (p < 0.001) in men on TU compared to men opting against TU. In the men on TU, age was associated with mortality (odds ratio (OR): 1.26, 95% confidence interval (CI): 1.13-1.40) in the nonlinear pattern expected in the Gompertz‒Makeham model. However, age was not associated with mortality in men not on TU (OR: 1.03, 95% CI: 0.98-1.08). T2DM status did not affect these associations. The association between age and mortality differed between men on TU and those opting against treatment. In untreated men, features of metabolic syndrome worsened, which perhaps minimized the relationship between age and mortality. In men on TU, these metabolic risk factors improved, perhaps restoring the association between age and mortality.


  • Open Access

    Endogenous Sex Hormones (FSH, Oestradiol, Testosterone and SHBG) and Type 2 Diabetes Risk in Postmenopausal Women: A Systematic Review and Meta-Analysis

    by Carolyn Chia-Yu Liu, Carola S. König, Sudarshan Ramachandran

    Background/Objectives: Menopause is accompanied by substantial changes in endogenous sex hormones that influence metabolic regulation. However, the associations of specific hormones with type 2 diabetes (T2D) risk in postmenopausal women remain inconsistent. This study aimed to quantify the relationships between incident T2D and follicle-stimulating hormone (FSH), oestradiol, testosterone, and sex hormone-binding globulin (SHBG), and to examine cross-sectional differences in hormone concentrations between postmenopausal women with and without T2D. Methods: MEDLINE, Embase and Cochrane CENTRAL were searched from database inception to 21 June 2024. Eligible studies included prospective cohort, nested case–control and case–control designs. Associations with incident T2D were pooled using Hartung–Knapp–Sidik–Jonkman random-effects meta-analysis. Both categorical and continuous estimates were extracted, prioritising maximally adjusted models. Risk of bias was assessed using ROBINS-E and the Newcastle–Ottawa Scale. Results: Sixteen studies (18 articles; n = 16,180) were included. Higher SHBG was consistently associated with lower T2D risk in cohort analyses (RR 0.55; 95% CI 0.38–0.72; I2 ≈ 0%). Higher FSH was also associated with lower risk (high vs. low: HR 0.55, 95% CI 0.29–0.81), although continuous estimates showed heterogeneity. Higher oestradiol was associated with increased T2D risk (RR 1.61, 95% CI 1.18–2.03; I2 ≈ 6%), while testosterone was not significantly associated with incident T2D (RR 1.11, 95% CI 0.73–1.50). Cross-sectional analyses indicated lower SHBG and higher testosterone in women with T2D. Conclusions: Endogenous hormone profiles and SHBG concentrations are associated with T2D in postmenopausal women, with the most consistent evidence for an inverse association between SHBG and incident T2D. Because the available evidence is observational and partly heterogeneous, these findings should be interpreted as associations rather than causal or clinically predictive effects. Standardised measurement, repeated pre-diagnostic sampling and external validation are required before these biomarkers can be considered for routine risk stratification.

  • Open Access

    System Sizing for Grid-Connected PV-Hybrid Storage with Hourly Dispatch Optimisation Under Inverter and Contracted Power Constraints -An Island Case Study

    by Abdelaziz Abualshawareb, Zahir Dehouche, Carola König, Ximena Schmidt, Ioana Pisica, Sergi Ribas

    Grid-connected energy communities on weak or capacity-limited feeders increasingly consider hybrid PVbattery-hydrogen systems, yet planning studies often size assets against annual balances while leaving the grid connection as an effectively unconstrained buffer. Here, we develop a boundary-centred planning architecture that couples long-horizon investment decisions to schedule-feasible operation. A genetic algorithm selects component capacities, inverter rating, and contracted import/export power, while a rolling-horizon MILP (model predictive control) resolves tariff-coupled dispatch with bounded daily load shifting. Using a public-sector community on the island of Formentera (Spain), we benchmark reactive load-following against predictive operation under 0 to 8% flexible demand. Predictive coordination reshapes both, sizing and energy flows by converting temporal foresight into "capacity value" at the point of common coupling. Relative to load-following, the optimiser tightens the contracted exchange envelope from ±78 kW to ±37 kW and reduces the inverter rating from 120 kW to 77 kW, while increasing PV utilisation and reducing grid import reliance to roughly 9-11% of demand. These gains are not driven by indiscriminate oversizing, but by differentiated storage roles: batteries absorb diurnal variability and preserve headroom, while hydrogen buffers longer-duration mismatches. Economically, modest flexibility amplifies the effect, reducing net present cost by 9% and lowering levelised electricity cost from 0.243 to 0.218 €/kWh. Together, the results show that hybrid community value is anchored in enforceable boundary control, and that limited behavioural adaptation can substitute for contracted capacity in weak-grid planning.

  • Open Access

    A Decentralised Plasma Gasification-PEM Fuel Cell System for Hospital Waste-to-Energy: From Waste Characterisation to Techno-Economic Validation

    by Carola König, Abdelaziz Abualshawareb, Zahir Dehouche, Gerard Jansen

    Hospital waste management remains a key barrier to healthcare decarbonisation. This study develops and validates an integrated plasma gasification-proton exchange membrane fuel cell (PEMFC) system for converting hospital offensive waste into hydrogen-based combined heat and power (CHP). A single composite feedstock from Hillingdon Hospital (London, UK) was used for dual thermodynamic validation in Aspen Plus and Cantera, achieving < 5 % deviation in hydrogen yield (0.042 kmol kg⁻¹) and establishing a transparent basis for modelling non-conventional wastes. The plasma gasifier achieved a cold gas efficiency of 46 % and syngas LHV of 8.27 MJ kg⁻¹, confirming efficient conversion of waste carbon to hydrogen-rich gas. PSA-grade hydrogen (10 mol s⁻¹ for 8,000 t yr⁻¹ feed) powered a PEMFC fitted to laboratory polarisation data (RMSE<2%), linking chemical conversion to realistic electrochemical output. System integration across three operational scenarios achieved waste-toenergy efficiencies of 17-21 % and waste-to-hydrogen efficiency of 32 %, corresponding to payback periods below four years and internal rates of return above 30 %. The analysis reveals that continuity of hydrogen utilisation, rather than peak process efficiency, governs economic resilience in decentralised systems. While based on a single feedstock and steady-state modelling, the framework provides a transferable validation route for heterogeneous wastes once compositional variability is characterised. The results position hospital waste treatment as a credible pathway toward self-reliant, low-carbon energy for institutional settings aligned with net-zero policy objectives.

  • Open Access

    Grid‐Constrained Sizing and Predictive Dispatch of a PV–Battery–Hydrogen Energy Community: An Island Case Study

    by Abdelaziz Abualshawareb, Zahir Dehouche, Carola S. König, Ximena Schmidt Rivera, Sergi Ribas, Ioana Pisica

    Grid‐connected energy communities on weak or capacity‐limited feeders increasingly consider hybrid photovoltaic (PV)–battery–hydrogen systems yet planning studies often size assets against annual balances while leaving the grid connection as an effectively unconstrained buffer. Here, we develop a boundary‐centred planning architecture that couples long‐horizon investment decisions to schedule‐feasible operation. A genetic algorithm (GA) selects component capacities, inverter rating, and contracted import/export power, while a rolling‐horizon (MILP) formulation implements model predictive control (MPC) resolves tariff‐coupled dispatch with bounded daily load shifting. Using a public‐sector community on the island of Formentera (Spain), we benchmark reactive load‐following against predictive operation under 0% to 8% flexible demand. Predictive coordination reshapes both, sizing and energy flows by converting temporal foresight into “capacity value” at the point of common coupling. Relative to load‐following, the optimiser tightens the contracted exchange envelope from ±78 to ±37 kW and reduces the inverter rating from 120 to 77 kW, while increasing PV utilisation and reducing grid import reliance to roughly 9%–11% of demand. These gains arise from coordinated storage operation: the battery provides mostly short‐term balancing, while hydrogen supplies a smaller secondary contribution through surplus absorption and occasional deficit support. Economically, modest flexibility amplifies the effect, reducing net present cost (NPC) by 9% and lowering levelised electricity cost (LCOE) from 0.243 to 0.218 €/kWh. Together, the results show that hybrid community value is anchored in enforceable boundary control, and that limited behavioural adaptation can substitute for contracted capacity in weak‐grid planning.

  • Open Access

    Agent-based socio-spatial modelling of coupled human-flood interactions along the UK coast

    by Morgan J Breen, Abiy S Kebede, Carola S König

    This study uses agent-based modelling (ABM) to assess the socio-hydrological impacts of structural coastal flood protections (SCFPs) under different climate change scenarios considering three contrasting UK case studies: Southport, Weston-super-Mare (WSM), and Portsmouth. By integrating extreme coastal water level (ECWL) projections and population dynamics, the ABM simulations reveal five distinct phases: Design, Implementation, Latency, Flood, and Post-Flood. The results highlight that the Latency phase, whereby SCFP initially stabilises affected population (AfP), inadvertently encourages population growth in residual risk areas. This process exacerbates long-term flood exposure, leading to significant increases in AfP when ECWL exceeds the SCFP crest height, negating gains in flood protection from the initial construction/upgrade. As such, Southport and WSM saw a significant increase in coastal population within protected floodplains, with these populations potentially having limited experience with flooding, preparedness, and consequently heightened vulnerability. Conversely, Portsmouth, with limited residential development near SCFPs, demonstrated how existing land-use and high population density can reduce the unintended socio-hydrological consequences of SCFPs in densely-populated coastal settings. These findings reveal two key pathways that influence coastal population in response to SCFPs: Land-use Driven, where non-residential land-use limits population increase, and Population Driven, where high-density areas limit further growth. This study advances our understanding of the coupled human-flood dynamics by evaluating how SCFPs can increase flood impacts in the long-term by influencing socio-spatial distribution over the short- to medium-term. Moreover, it demonstrates how ABMs can provide valuable insights by simulating complex coupled human-flood dynamics; critical for supporting adaptive, resilient coastal management strategies in a changing climate.

  • Open Access

    Testosterone undecanoate is associated with improved ageing male symptoms score in men with type 2 diabetes and adult-onset testosterone deficiency: re-analyzed results from a randomised controlled trial

    by Pravinath Ramachandran, Michael Zitzmann, Carola S. König, Joseph Mulhern, Sudarshan Ramachandran, Geoffrey Hackett

    Aim: To evaluate changes in quality of life via the ageing male symptom scale (AMSS) and somatic, psychological, and sexual sub-scales following testosterone undecanoate (TU) or placebo (P) treatment in men with type 2 diabetes mellitus (T2DM) and adult-onset testosterone deficiency (TD) via a re-analysis of the BLAST (Burntwood, Lichfield, Atherstone, Sutton Coldfield, and Tamworth) randomised controlled trial (RCT). Methods: Analysis of data from the BLAST RCT in men with T2DM and adult-onset TD was performed. Summation baseline and study-end AMSS data were available in 170 men (94: P; 76: TU) with subscale data available in 82 men. Rank-sum and sign-rank tests determined inter/intra-group differences, whilst linear/multiple regression models identified predictors of AMSS change. Results: AMSS improved significantly in P [–2 (median), p = 0.010] and TU [–6 (median), p < 0.0001)] arms, with greater improvement observed in men on TU (p = 0.014). No significant change was seen in either arm with baseline AMSS < 27 (asymptomatic). TU was significantly associated with AMSS improvement in all symptomatic AMSS categories. Improvement in the P arm was confined to men with baseline AMSS > 49. In the cohort with subscale AMSS data, TU was associated with improvements in somatic, psychological, and sexual subscales, whilst improvement was limited to the somatic subscale in the men on P. TU (reference: P) and higher baseline AMSS were significantly and independently associated with AMSS improvement. The improvement in summation AMSS associated with TU (reference: P) was only evident in men with mild depression and no anxiety (based on baseline Hospital Anxiety and Depression Scale data). Conclusions: TU appeared associated with improved AMSS (summation and subscales) in men with T2DM and adult-onset TD demonstrating symptoms (AMSS ≥ 27) with this benefit mediated by levels of depression and anxiety (European Union Clinical Trials Register, EudraCT 2008-000931-16).


  • Open Access

    Adult-onset testosterone deficiency: the usefulness of hormone replacement in reducing mortality in men with this common age-related condition

    by Amar Mann, Richard C. Strange, Geoffrey Hackett, Carola König, Sudarshan Ramachandran

    Adult-onset testosterone deficiency (TD) in men is diagnosed by the finding of low serum testosterone levels and recognised, associated symptoms. The condition has high prevalence in men over 50 years of age, particularly those with type 2 diabetes (T2DM). Accumulating data show adult-onset TD is associated with increased mortality risk. We review the literature and consider the evidence suggesting testosterone therapy (TTh) reduces mortality, especially in men with T2DM. We previously reported that in the Burntwood Lichfield Atherstone Sutton Coldfield Tamworth (BLAST) study screened cohort of men with adult-onset TD and T2DM adult-onset TD was associated with increased mortality with TTh decreasing this higher mortality. The data hinted that the effect was greater in older men. We confirmed this observation with statistical analyses to study the effect of age on the association between adult-onset TD and mortality; Cox regression analysis demonstrated that the reduced risk (hazard ratio: 0.61, 95% CI: 0.38–0.96) following TTh was restricted to men above the median age of 65.89 years. Finally, we speculate on putative mechanisms that may mediate these associations. Heterogeneity in men with adult-onset TD is expected in view of its definition of low testosterone levels together with associated clinical phenotypes that are not always directly related. Many of these classifying phenotypes are associated with increased mortality. Thus, it is perhaps possible that mechanism(s) of all-cause mortality reduction following TTh is via the impact on these associated phenotypes such as the metabolic syndrome (MetS), hyperglycaemia, hypertension, dyslipidaemia, low haematocrit, sex hormone binding levels, erectile dysfunction, etc. We propose that further research studying the effect of TTh takes heterogeneity into account.